Skip to content

Clinical trials

Completed Adenocarcinoma trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Status: Completed Country / region: Hong Kong Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20081
20092
20142
20161
20171
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ariad Pharmaceuticals1
Boehringer Ingelheim1
Celgene1
Daiichi Sankyo Co., Ltd.1
Genzyme, a Sanofi Company1
Hoffmann-La Roche1
Imunon1
NantCell, Inc.1
Novartis Pharmaceuticals1
Queensland Centre for Gynaecological Cancer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma10
Carcinoma5
Carcinoma, Non-Small-Cell Lung4
Neoplasms4
Digestive System Diseases3
Digestive System Neoplasms3
Neoplasms by Site3
Carcinoma, Large Cell2
Carcinoma, Squamous Cell2
Colonic Neoplasms2

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.